FDA Updates for Week of November 1, 2021 - Managed Healthcare Executive

Retrieved on: 2021-11-06 19:15:47

Tags for this article:

Chemical compounds

Antiviral drugs

COVID-19 drug development

Chronic myelogenous leukemia

Remdesivir

Merck

Click the tags to see associated articles and topics

FDA Updates for Week of November 1, 2021 - Managed Healthcare Executive. View article details on HISWAI: https://www.managedhealthcareexecutive.com/view/fda-updates-for-week-of-november-1-2021

Excerpt

... is a confirmatory study that randomized patients with COVID-19 respiratory failure to Zyesami or Veklury (remdesivir) and placebo.

Article found on: www.managedhealthcareexecutive.com

View Original Article